How to calculate a PASI score accurately across skin tones
PASI is widely used to record the extent and severity of psoriasis, but it is easy to score inconsistently. Estimating the affected area, distinguishing slight from marked plaque signs and recognising erythema across different skin tones can all influence the final result.
This practical guide explains how to calculate a PASI score, how to measure improvement from baseline and where the score can miss clinically important disease.
The Bright Med PASI Calculator provides a guided way to record the four body regions and calculate the result. It can reduce arithmetic errors, but the clinical component scores still depend on an appropriately trained healthcare professional.
Prefer guided scoring? Use the Bright Med PASI Calculator to work through each body region and calculate the total score.
What is a PASI score?
PASI stands for Psoriasis Area and Severity Index. It combines the extent of psoriasis with three visible features of the plaques:
Erythema, meaning inflammatory colour change
Induration, meaning plaque thickness or elevation
Desquamation, meaning scaling
These features are assessed separately in four body regions:
Head, weighted at 0.1
Upper limbs, weighted at 0.2
Trunk, weighted at 0.3
Lower limbs, weighted at 0.4
The final PASI ranges from 0 to 72. A score of 0 indicates no psoriasis recorded. A score of 72 is the theoretical maximum.
How to calculate a PASI score
Step 1: Assess the four body regions separately
Assess the head, upper limbs, trunk and lower limbs independently. Do not estimate a single average for the whole body. Plaque severity and affected area can differ considerably between regions.
Step 2: Estimate the affected area in each region
Estimate the percentage of each individual body region affected by psoriasis. Convert that percentage to an area score:
No involvement: 0
Less than 10%: 1
10% to 29%: 2
30% to 49%: 3
50% to 69%: 4
70% to 89%: 5
90% to 100%: 6
The percentage relates to the region being assessed, not the patient’s total body surface area. When assessing the upper limbs, for example, consider both upper limbs together as that region.
Step 3: Score erythema, thickness and scale
For each body region, score erythema, induration and desquamation from 0 to 4:
None: 0
Slight: 1
Moderate: 2
Marked: 3
Very marked: 4
Score the signs of active psoriasis. Residual post-inflammatory hyperpigmentation or hypopigmentation should not automatically be scored as active erythema.
Step 4: Calculate the subtotal for each region
Use this calculation for each region:
Regional PASI = (erythema + induration + desquamation) × area score × body-region weight
Step 5: Add the four regional subtotals
The complete formula is:
PASI = 0.1(Eh + Ih + Dh)Ah + 0.2(Eu + Iu + Du)Au + 0.3(Et + It + Dt)At + 0.4(El + Il + Dl)Al
In this formula:
E means erythema
I means induration
D means desquamation
A means area score
h, u, t and l mean head, upper limbs, trunk and lower limbs
A worked PASI example
Consider this fictional assessment:
Head
Erythema 1 + induration 1 + scale 1Area score 1 × weight 0.1Regional subtotal: 0.3
Upper limbs
Erythema 2 + induration 2 + scale 2Area score 2 × weight 0.2Regional subtotal: 2.4
Trunk
Erythema 2 + induration 2 + scale 2Area score 2 × weight 0.3Regional subtotal: 3.6
Lower limbs
Erythema 3 + induration 2 + scale 2Area score 3 × weight 0.4Regional subtotal: 8.4
The total PASI is:
0.3 + 2.4 + 3.6 + 8.4 = 14.7
The arithmetic is relatively straightforward. The more difficult part is selecting the component scores consistently. A structured calculator helps with the arithmetic but does not replace clinical training.
Assessing erythema across skin tones
Erythema does not always appear bright red. The British Association of Dermatologists advises that inflammatory colour change can appear pink, red or purple. In richly pigmented skin, it may present as subtle darkening of the person’s usual skin tone.
NICE specifically warns that erythema may be underestimated in people with darker skin types. This matters because erythema contributes directly to the PASI result.
When assessing erythema:
Compare affected skin with nearby unaffected skin in good, consistent lighting.
Look for purple, violaceous, grey, ashen or darker change rather than relying only on visible redness.
Assess plaque borders, scale and thickness separately.
Where clinically appropriate, use touch to assess plaque elevation, texture, local heat and swelling.
Distinguish active inflammation from residual pigment alteration.
Record uncertainty and use comparable lighting and positioning for repeat assessments.
Skin tone should not be inferred from race or ethnicity. Fitzpatrick skin type was developed to describe response to ultraviolet exposure. It is not a complete description of visible skin tone or inflammatory change. Record what you observe rather than relying on assumptions.
The Bright Med PASI Calculator includes guided scoring and visual support designed to make assessment more consistent across different skin tones. It should be used alongside clinical judgement, current guidance and local policy.
Common PASI scoring errors
Using total body area instead of regional area
The area category is calculated separately within each body region. Mixing a regional estimate with whole-body surface area can distort the result.
Using one average plaque score for the whole patient
PASI requires separate severity scores for each region. A patient may have thin plaques on the trunk and markedly thicker plaques on the lower limbs.
Scoring pigment alteration as active disease
Post-inflammatory hyperpigmentation or hypopigmentation may remain after active psoriasis has improved. Consider thickness, scale, symptoms and change over time rather than colour alone.
Confusing PASI 75 with a score of 75
PASI 75 means a 75% reduction from the baseline PASI. It is not a total score of 75. The maximum possible PASI is 72.
Allowing the number to replace clinical assessment
A modest PASI does not always mean modest disease. Localised psoriasis affecting the face, scalp, palms, soles, flexures or genitals can have a major functional or psychological impact. Nail disease, symptoms, psoriatic arthritis and quality of life also require separate consideration.
What do PASI 75 and PASI 90 mean?
PASI response is the percentage reduction from the baseline score:
Percentage improvement = (baseline PASI − current PASI) ÷ baseline PASI × 100
If the baseline PASI was 20 and the current PASI is 5:
(20 − 5) ÷ 20 × 100 = 75%
The patient has therefore achieved PASI 75.
The same method is used for:
PASI 50: at least 50% improvement from baseline
PASI 75: at least 75% improvement from baseline
PASI 90: at least 90% improvement from baseline
PASI 100: a 100% reduction from baseline
Treatment decisions must follow the relevant NICE guidance, current product information and local commissioning pathway. The PASI response is one part of that decision.
What PASI does not measure
PASI is useful, but it does not provide a complete assessment of psoriasis. It does not directly measure:
Quality of life or psychological impact
Pain, itch or sleep disturbance
Nail disease
Psoriatic arthritis
The disproportionate impact of high-impact sites
The patient’s treatment goals and preferences
NICE recommends considering body surface area, high-impact and difficult-to-treat sites, nail disease, symptoms and physical, psychological and social wellbeing. The Dermatology Life Quality Index may form part of this broader assessment in adults.
NICE also states that PASI and body surface area have not been validated for use in children and young people.
Use the Bright Med PASI Calculator
The Bright Med PASI Calculator guides you through the head, upper limbs, trunk and lower limbs before calculating the total score. Its structured format can reduce missed fields and arithmetic errors, while its visual support across skin tones can aid a more inclusive assessment.
The calculator supports clinical practice. It does not diagnose psoriasis, select the component scores, determine treatment eligibility or replace the healthcare professional responsible for the assessment.
Frequently asked questions
What is the maximum PASI score?
The theoretical maximum is 72. A score of 0 indicates no psoriasis recorded in the four assessed body regions.
Does a PASI above 10 automatically mean that systemic treatment is needed?
No. NICE includes a PASI above 10 as one example of extensive disease when considering conventional systemic treatment, but only within a broader clinical assessment. The full guideline, effect on wellbeing, response to previous treatment, high-impact sites and individual circumstances must be considered.
Can PASI be used in children?
NICE states that PASI and body surface area are not validated for children and young people. Paediatric assessment should follow specialist guidance and an age-appropriate clinical approach.
Does PASI include scalp and nail psoriasis?
Skin involvement in the head region can contribute to PASI, but the score may underrepresent severe localised disease at high-impact sites. PASI does not directly score nail disease.
Is PASI a diagnostic tool?
No. PASI records the extent and visible severity of established psoriasis. It does not confirm the diagnosis or distinguish psoriasis from another condition.
References
British Association of Dermatologists. Skin diversity erythema description guidance.
Merola JF, et al. Improving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality Improvement. JAMA Dermatology.
Sampogna F, et al. Performance of the Self-administered Psoriasis Area and Severity Index in Evaluating Clinical and Sociodemographic Subgroups of Patients With Psoriasis. Archives of Dermatology.
Professional-use statement: This article provides educational information for qualified healthcare professionals. It does not replace clinical judgement, current national guidance, product information or local governance.
